Eli Lilly has announced a strong initial performance for its newly released oral weight-loss medication, Foundayo, which has already been adopted by over 20,000 patients in the weeks following its market debut. According to company leadership, the drug is currently maintaining a steady growth trajectory, with approximately 1,000 new patients initiating treatment each day. This […]